Samuel J. Daniels
AstraZeneca (United Kingdom)(GB)AstraZeneca (South Korea)(KR)AstraZeneca (Netherlands)(NL)AstraZeneca (Singapore)(SG)AstraZeneca (Poland)(PL)AstraZeneca (Spain)(ES)
Publications by Year
Research Areas
Liver Disease Diagnosis and Treatment, Liver physiology and pathology, Cardiovascular Disease and Adiposity, Liver Diseases and Immunity, Liver Disease and Transplantation
Most-Cited Works
- → The good and the bad collagens of fibrosis – Their role in signaling and organ function(2017)489 cited
- → ADAPT: An Algorithm Incorporating PRO‐C3 Accurately Identifies Patients With NAFLD and Advanced Fibrosis(2018)248 cited
- → Collagen biology and non‐invasive biomarkers of liver fibrosis(2020)193 cited
- → Serological Assessment of Activated Fibroblasts by alpha-Smooth Muscle Actin (α-SMA): A Noninvasive Biomarker of Activated Fibroblasts in Lung Disorders(2018)82 cited
- → Review article: the signalling and functional role of the extracellular matrix in the development of liver fibrosis(2020)59 cited
- → Is the Total Amount as Important as Localization and Type of Collagen in Liver Fibrosis Attributable to Steatohepatitis?(2019)43 cited